401 Odcinki

  1. Episode 41: The Uromigos World Tour lands in Brazil - Fernando Maluf talks about prostate cancer and recent research in Brazil

    Opublikowany: 25.06.2020

  2. Episode 40: The Uromigos World Tour moves to France - Bernard Escudier discusses 2nd line therapy in renal cancer and Tivozanib

    Opublikowany: 22.06.2020

  3. Episode 39: The Uromigos World Tour - Renal Cancer and IMDC Risk with Danny Heng in Calgary

    Opublikowany: 18.06.2020

  4. Episode 38: The Uromigos Virtual World Tour - starting in Vancouver with Atezolizumab in NMIBC

    Opublikowany: 16.06.2020

  5. Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC with Jonathan Rosenberg

    Opublikowany: 1.06.2020

  6. Episode 36: Dr. Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations

    Opublikowany: 1.06.2020

  7. Episode 35: Maintenance Avelumab in Bladder Cancer (LBA1)

    Opublikowany: 31.05.2020

  8. Episode 34: Savolitinib in Renal Papillary Cancer - A Major Breakthrough?

    Opublikowany: 30.05.2020

  9. Episode 33: Adjuvant Atezolizumab in Urothelial Cancer

    Opublikowany: 29.05.2020

  10. Episode 32: A Phase 2 Study of PSMA PET in Prostate Cancer with Thomas Hope from ASCO 2020

    Opublikowany: 29.05.2020

  11. Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer

    Opublikowany: 29.05.2020

  12. Episode 30: Update on Axitinib plus Pembrolizumab in Renal Cancer (KEYNOTE 426)

    Opublikowany: 29.05.2020

  13. Episode 29: PSMA PET at ASCO 2020 with Mike Morris

    Opublikowany: 29.05.2020

  14. Episode 28: Targeting VHL Syndrome Renal Cancer with a HIF Inhibitor - A Game Changer

    Opublikowany: 29.05.2020

  15. Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC-19)

    Opublikowany: 29.05.2020

  16. Episode 26: Joaquim Bellmunt and Muscle Invasive Bladder Cancer prior to ASCO 2020

    Opublikowany: 19.05.2020

  17. Episode 25: Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial

    Opublikowany: 19.05.2020

  18. Episode 24: A Study of COVID-19 in Lung Cancer Shows High Mortality

    Opublikowany: 28.04.2020

  19. Episode 23: Atezolizumab and Enzalutamide versus Enzalutamide Prostate Cancer

    Opublikowany: 28.04.2020

  20. Episode 22: COVID-19 and Cardiovascular Disease

    Opublikowany: 22.04.2020

19 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site